BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9111077)

  • 1. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells.
    Daude N; Lehmann S; Harris DA
    J Biol Chem; 1997 Apr; 272(17):11604-12. PubMed ID: 9111077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.
    Lehmann S; Harris DA
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5610-4. PubMed ID: 8643624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant and infectious prion proteins display common biochemical properties in cultured cells.
    Lehmann S; Harris DA
    J Biol Chem; 1996 Jan; 271(3):1633-7. PubMed ID: 8576163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells.
    Lehmann S; Harris DA
    J Biol Chem; 1997 Aug; 272(34):21479-87. PubMed ID: 9261166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
    Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
    J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells.
    Lehmann S; Daude N; Harris DA
    Brain Res Mol Brain Res; 1997 Dec; 52(1):139-45. PubMed ID: 9450686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
    J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
    Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.
    Raeber AJ; Borchelt DR; Scott M; Prusiner SB
    J Virol; 1992 Oct; 66(10):6155-63. PubMed ID: 1356161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biological studies of the prion protein.
    Harris DA
    Curr Issues Mol Biol; 1999; 1(1-2):65-75. PubMed ID: 11475702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.